10/9/2016 1
DefinitionDefinition
Normal hemostasis
Tightly regulated processes
Maintain blood in a fluid state in normal vessels
Thrombosis
Pathologic counterpartPathologic counterpart
Thrombus within intact vessels
Three components:
1.
10/9/2016 2
10/9/2016 3
EndotheliumEndothelium
Key players in the regulation of
homeostasis
Have Anti- and prothrombotic activities ;
Thrombus formation
Propagation, or
Dissolution occursDissolution occurs
exhibit
Antithrombotic activity:
10/9/2016 4
Mediated by;
Physical Barrier
Prostacyclin (PGI2)
AntiAntithromboticthrombotic activityactivity
Prostacyclin (PGI2)
Nitric oxide (NO)
ADPase
inhibits platelet aggregation
10/9/2016 5
These effects are mediated by:
Endothelial membrane-associated
They are cofactors
Enhance plasma protein antithrombin III activityEnhance plasma protein antithrombin III activity
modulates the activity of Thrombin
Cell surface protein
Directly inhibits tissue factor,VIIa & Xa
10/9/2016 6
3. Fibrinolytic properties3. Fibrinolytic properties
Endothelial cells synthesize:
Tissue-type plasminogen activator (t-PA)
A protease that cleaves plasminogen to form
plasmin
PlasminPlasmin, in turn, cleaves fibrin to degradePlasminPlasmin, in turn, cleaves fibrin to degrade
thrombi
10/9/2016 7
Exposure & contact of platelets to ECM
Adhesion mediated by vWF
Endothelial release of tissue factor
Catalytic function factors IXa and Xa
Plasminogen activator inhibitors (PAIs)
Limit fibrinolysis & favor thrombosis
10/9/2016 8
In summaryIn summary
Intact, nonactivated endothelial cells Antithrombotic
Endothelial injury or activation Prothrombotic
10/9/2016 9
PlateletsPlatelets
Disc-shaped
AnucleateAnucleate cell fragments
2-3 ꭒm in diameter
8-10 days of half-life
Originate from MEGAkaryocytesMEGAkaryocytesOriginate from MEGAkaryocytesMEGAkaryocytes
Play a critical role in normal hemostasishemostasis
vascular defects
Provide a surface for activated coagulation factors
Contain 2 types of cytoplasmic granules
10/9/2016 10
P-selectin
Fibrinogen
Fibronectin,
Factors V and VIII
Platelet factor 4
PDGF
ADP
ATP
Calcium
Histamine
Serotonin
Epinephrine
10/9/2016 11
PDGF
TGF-β
Epinephrine
Normal HemostasisNormal Hemostasis
• general sequence of events in hemostasis
1.Transient arteriolar vasoconstriction
Mediated by:
Reflex Neurogenic mechanisms
Myogenic reflex contraction, andMyogenic reflex contraction, and
Endothelin
10/9/2016 12
2. Primary hemostasis
Endothelial injury exposes HTSECM,
Patelet adherence and activation
Dramatic shape changeDramatic shape change
Release of secretory granules
Recruit additional platelets (aggregation) to form a
hemostatic plug
Platelet adhesionPlatelet adhesion
Via interactions with vWF
Other components of the ECM (e.g., fibronectin)
10/9/2016 14
Degranulation
Importance
Ca+2Ca+2Ca+2Ca+2 is required in the coagulation cascade
ADPADPADPADP is a potent platelet aggregator
Platelet activation negatively chargedPlatelet activation negatively charged
phospholipids on their surfaces
Bind calcium and serve as critical nucleation
sites
10/9/2016 15
Follows adhesion and granule release
• ADP
• Noncleaved fibrinogen
• TxA2 amplifies platelet aggregation primaryprimary
hemostatic plughemostatic plug
Aggregation is reversibleAggregation is reversible
10/9/2016 16
3. Secondary Hemostasis
(factor III or thromboplastin)(factor III or thromboplastin)
Membrane-bound procoagulant glycoprotein
synthesized by endothelial cells
Exposed at the site of injury
With factor VII , in vivo initiator of the coagulationWith factor VII , in vivo initiator of the coagulation
cascade
Thrombin generation
Cleavage of fibrinogen into insoluble fibrin
Creation a fibrin meshwork
Further platelet recruitment and activation
10/9/2016 17
Coagulation CascadeCoagulation Cascade
The 3rd arm of the hemostatic process
Amplifying series of enzymatic conversions
Each step proteolytically cleaves an inactive
proenzyme
ThrombinThrombin formation is the targetThrombinThrombin formation is the target
10/9/2016 18
10/9/2016 19
Each reaction in the pathway results from
interaction of
•• EnzymeEnzyme Activated coagulation factor
•• SubstrateSubstrate proenzyme coagulation factor
•••• CofactorCofactor Reaction accelerator
Assembled on a phospholipid surface and
Held together by calcium ions
10/9/2016 21

Normal hemostasis and coagulation

  • 1.
  • 2.
    DefinitionDefinition Normal hemostasis Tightly regulatedprocesses Maintain blood in a fluid state in normal vessels Thrombosis Pathologic counterpartPathologic counterpart Thrombus within intact vessels Three components: 1. 10/9/2016 2
  • 3.
  • 4.
    EndotheliumEndothelium Key players inthe regulation of homeostasis Have Anti- and prothrombotic activities ; Thrombus formation Propagation, or Dissolution occursDissolution occurs exhibit Antithrombotic activity: 10/9/2016 4
  • 5.
    Mediated by; Physical Barrier Prostacyclin(PGI2) AntiAntithromboticthrombotic activityactivity Prostacyclin (PGI2) Nitric oxide (NO) ADPase inhibits platelet aggregation 10/9/2016 5
  • 6.
    These effects aremediated by: Endothelial membrane-associated They are cofactors Enhance plasma protein antithrombin III activityEnhance plasma protein antithrombin III activity modulates the activity of Thrombin Cell surface protein Directly inhibits tissue factor,VIIa & Xa 10/9/2016 6
  • 7.
    3. Fibrinolytic properties3.Fibrinolytic properties Endothelial cells synthesize: Tissue-type plasminogen activator (t-PA) A protease that cleaves plasminogen to form plasmin PlasminPlasmin, in turn, cleaves fibrin to degradePlasminPlasmin, in turn, cleaves fibrin to degrade thrombi 10/9/2016 7
  • 8.
    Exposure & contactof platelets to ECM Adhesion mediated by vWF Endothelial release of tissue factor Catalytic function factors IXa and Xa Plasminogen activator inhibitors (PAIs) Limit fibrinolysis & favor thrombosis 10/9/2016 8
  • 9.
    In summaryIn summary Intact,nonactivated endothelial cells Antithrombotic Endothelial injury or activation Prothrombotic 10/9/2016 9
  • 10.
    PlateletsPlatelets Disc-shaped AnucleateAnucleate cell fragments 2-3ꭒm in diameter 8-10 days of half-life Originate from MEGAkaryocytesMEGAkaryocytesOriginate from MEGAkaryocytesMEGAkaryocytes Play a critical role in normal hemostasishemostasis vascular defects Provide a surface for activated coagulation factors Contain 2 types of cytoplasmic granules 10/9/2016 10
  • 11.
    P-selectin Fibrinogen Fibronectin, Factors V andVIII Platelet factor 4 PDGF ADP ATP Calcium Histamine Serotonin Epinephrine 10/9/2016 11 PDGF TGF-β Epinephrine
  • 12.
    Normal HemostasisNormal Hemostasis •general sequence of events in hemostasis 1.Transient arteriolar vasoconstriction Mediated by: Reflex Neurogenic mechanisms Myogenic reflex contraction, andMyogenic reflex contraction, and Endothelin 10/9/2016 12
  • 13.
    2. Primary hemostasis Endothelialinjury exposes HTSECM, Patelet adherence and activation Dramatic shape changeDramatic shape change Release of secretory granules Recruit additional platelets (aggregation) to form a hemostatic plug
  • 14.
    Platelet adhesionPlatelet adhesion Viainteractions with vWF Other components of the ECM (e.g., fibronectin) 10/9/2016 14
  • 15.
    Degranulation Importance Ca+2Ca+2Ca+2Ca+2 is requiredin the coagulation cascade ADPADPADPADP is a potent platelet aggregator Platelet activation negatively chargedPlatelet activation negatively charged phospholipids on their surfaces Bind calcium and serve as critical nucleation sites 10/9/2016 15
  • 16.
    Follows adhesion andgranule release • ADP • Noncleaved fibrinogen • TxA2 amplifies platelet aggregation primaryprimary hemostatic plughemostatic plug Aggregation is reversibleAggregation is reversible 10/9/2016 16
  • 17.
    3. Secondary Hemostasis (factorIII or thromboplastin)(factor III or thromboplastin) Membrane-bound procoagulant glycoprotein synthesized by endothelial cells Exposed at the site of injury With factor VII , in vivo initiator of the coagulationWith factor VII , in vivo initiator of the coagulation cascade Thrombin generation Cleavage of fibrinogen into insoluble fibrin Creation a fibrin meshwork Further platelet recruitment and activation 10/9/2016 17
  • 18.
    Coagulation CascadeCoagulation Cascade The3rd arm of the hemostatic process Amplifying series of enzymatic conversions Each step proteolytically cleaves an inactive proenzyme ThrombinThrombin formation is the targetThrombinThrombin formation is the target 10/9/2016 18
  • 19.
  • 21.
    Each reaction inthe pathway results from interaction of •• EnzymeEnzyme Activated coagulation factor •• SubstrateSubstrate proenzyme coagulation factor •••• CofactorCofactor Reaction accelerator Assembled on a phospholipid surface and Held together by calcium ions 10/9/2016 21